TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹235 Cr | ₹101 Cr | ₹-142 Cr | ₹-300 Cr | ₹-422 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of TORRENT PHARMACEUTICALS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹235 Cr |
| Mar2024 | ₹101 Cr |
| Mar2023 | ₹-142 Cr |
| Mar2022 | ₹-300 Cr |
| Mar2021 | ₹-422 Cr |
How is Deferred Tax Assets / Liabilities of TORRENT PHARMACEUTICALS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹235 Cr | 132.43 | |
| Mar2024 | ₹101 Cr | Positive | |
| Mar2023 | ₹-142 Cr | Negative | |
| Mar2022 | ₹-300 Cr | Negative | |
| Mar2021 | ₹-422 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹129,077.6 Cr | 1.5% | 3.4% | 12.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹424,982.0 Cr | -0.7% | -0.5% | -3.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,878.0 Cr | 2.8% | 2.2% | 10.8% | Stock Analytics | |
| CIPLA | ₹122,175.0 Cr | 0.8% | 0.1% | 3.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,154.0 Cr | 0.4% | 3.2% | 0.3% | Stock Analytics | |
| MANKIND PHARMA | ₹90,303.2 Cr | 3.9% | -2.5% | -22.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | 1.5% |
3.4% |
12.4% |
| SENSEX | 0.4% |
-0.1% |
6.1% |
You may also like the below Video Courses